Bio-Rad Laboratories Free Cash Flow 2010-2023 | BIO
Bio-Rad Laboratories annual/quarterly free cash flow history and growth rate from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Bio-Rad Laboratories free cash flow for the quarter ending December 31, 2023 was 218.47, a year-over-year.
- Bio-Rad Laboratories free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- Bio-Rad Laboratories annual free cash flow for 2023 was $0.218B, a 167% increase from 2022.
- Bio-Rad Laboratories annual free cash flow for 2022 was $0.082B, a 84.73% decline from 2021.
- Bio-Rad Laboratories annual free cash flow for 2021 was $0.536B, a 12.44% increase from 2020.
| Bio-Rad Laboratories Annual Free Cash Flow | |
|---|---|
| 2023 | 218.47 |
| 2022 | 81.83 |
| 2021 | 535.77 |
| 2020 | 476.48 |
| 2019 | 359.49 |
| 2018 | 159.98 |
| 2017 | -7.11 |
| 2016 | 75.03 |
| 2015 | 74.29 |
| 2014 | 152.54 |
| 2013 | 63.69 |
| 2012 | 129.94 |
| 2011 | 160.08 |
| 2010 | 138.65 |
| 2009 | 258.28 |
| Bio-Rad Laboratories Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | 218.47 |
| 2023-09-30 | 179.57 |
| 2023-06-30 | 125.86 |
| 2023-03-31 | 62.39 |
| 2022-12-31 | 81.83 |
| 2022-09-30 | 36.92 |
| 2022-06-30 | 53.46 |
| 2022-03-31 | 17.42 |
| 2021-12-31 | 535.77 |
| 2021-09-30 | 421.09 |
| 2021-06-30 | 225.31 |
| 2021-03-31 | 94.08 |
| 2020-12-31 | 476.48 |
| 2020-09-30 | 230.96 |
| 2020-06-30 | 115.26 |
| 2020-03-31 | 41.26 |
| 2019-12-31 | 359.49 |
| 2019-09-30 | 221.25 |
| 2019-06-30 | 152.59 |
| 2019-03-31 | 19.39 |
| 2018-12-31 | 159.98 |
| 2018-09-30 | 108.81 |
| 2018-06-30 | 68.41 |
| 2018-03-31 | 13.18 |
| 2017-12-31 | -7.11 |
| 2017-09-30 | -50.40 |
| 2017-06-30 | -58.63 |
| 2017-03-31 | -95.52 |
| 2016-12-31 | 75.03 |
| 2016-09-30 | 25.37 |
| 2016-06-30 | 12.86 |
| 2016-03-31 | -32.74 |
| 2015-12-31 | 74.29 |
| 2015-09-30 | 66.29 |
| 2015-06-30 | 8.74 |
| 2015-03-31 | 2.37 |
| 2014-12-31 | 152.54 |
| 2014-09-30 | 152.61 |
| 2014-06-30 | 89.27 |
| 2014-03-31 | 43.10 |
| 2013-12-31 | 63.69 |
| 2013-09-30 | 20.90 |
| 2013-06-30 | -13.76 |
| 2013-03-31 | -10.06 |
| 2012-12-31 | 129.94 |
| 2012-09-30 | 68.11 |
| 2012-06-30 | 33.32 |
| 2012-03-31 | 0.61 |
| 2011-12-31 | 160.08 |
| 2011-09-30 | 114.18 |
| 2011-06-30 | 87.64 |
| 2011-03-31 | 2.00 |
| 2010-12-31 | 138.65 |
| 2010-09-30 | 69.76 |
| 2010-06-30 | 23.10 |
| 2010-03-31 | 6.14 |
| 2009-12-31 | 258.28 |
| 2009-09-30 | 160.42 |
| 2009-06-30 | 78.47 |
| 2009-03-31 | -12.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $8.583B | $2.671B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Medtronic (MDT) | Ireland | $112.493B | 15.93 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |